news
Scientists have shown that a Selenium-based drug-molecule called ebselen and…
2 September 2020 | By Victoria Rees (Drug Target Review)
Scientists have shown that a Selenium-based drug-molecule called ebselen and other novel compounds can delay ALS onset in mouse models.